335 related articles for article (PubMed ID: 8972190)
1. The Myc negative autoregulation mechanism requires Myc-Max association and involves the c-myc P2 minimal promoter.
Facchini LM; Chen S; Marhin WW; Lear JN; Penn LZ
Mol Cell Biol; 1997 Jan; 17(1):100-14. PubMed ID: 8972190
[TBL] [Abstract][Full Text] [Related]
2. Opposite regulation of gene transcription and cell proliferation by c-Myc and Max.
Gu W; Cechova K; Tassi V; Dalla-Favera R
Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2935-9. PubMed ID: 8385351
[TBL] [Abstract][Full Text] [Related]
3. Analysis of c-Myc and Max binding to the c-myc promoter: evidence that autosuppression occurs via an indirect mechanism.
Buckle RS; Méchali M
Oncogene; 1995 Mar; 10(6):1249-55. PubMed ID: 7700652
[TBL] [Abstract][Full Text] [Related]
4. Do products of the myc proto-oncogene play a role in transcriptional regulation of the prothymosin alpha gene?
Mol PC; Wang RH; Batey DW; Lee LA; Dang CV; Berger SL
Mol Cell Biol; 1995 Dec; 15(12):6999-7009. PubMed ID: 8524267
[TBL] [Abstract][Full Text] [Related]
5. Discrimination between different E-box-binding proteins at an endogenous target gene of c-myc.
Desbarats L; Gaubatz S; Eilers M
Genes Dev; 1996 Feb; 10(4):447-60. PubMed ID: 8600028
[TBL] [Abstract][Full Text] [Related]
6. The tmp gene, encoding a membrane protein, is a c-Myc target with a tumorigenic activity.
Ben-Porath I; Yanuka O; Benvenisty N
Mol Cell Biol; 1999 May; 19(5):3529-39. PubMed ID: 10207076
[TBL] [Abstract][Full Text] [Related]
7. Oncogenic activity of the c-Myc protein requires dimerization with Max.
Amati B; Brooks MW; Levy N; Littlewood TD; Evan GI; Land H
Cell; 1993 Jan; 72(2):233-45. PubMed ID: 8425220
[TBL] [Abstract][Full Text] [Related]
8. Design and properties of a Myc derivative that efficiently homodimerizes.
Soucek L; Helmer-Citterich M; Sacco A; Jucker R; Cesareni G; Nasi S
Oncogene; 1998 Nov; 17(19):2463-72. PubMed ID: 9824157
[TBL] [Abstract][Full Text] [Related]
9. Myc-Max heterodimers activate a DEAD box gene and interact with multiple E box-related sites in vivo.
Grandori C; Mac J; Siëbelt F; Ayer DE; Eisenman RN
EMBO J; 1996 Aug; 15(16):4344-57. PubMed ID: 8861962
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of tumor growth by direct intratumoral gene transfer of herpes simplex virus thymidine kinase gene with DNA-liposome complexes.
Sugaya S; Fujita K; Kikuchi A; Ueda H; Takakuwa K; Kodama S; Tanaka K
Hum Gene Ther; 1996 Jan; 7(2):223-30. PubMed ID: 8788173
[TBL] [Abstract][Full Text] [Related]
11. Activation domains of L-Myc and c-Myc determine their transforming potencies in rat embryo cells.
Barrett J; Birrer MJ; Kato GJ; Dosaka-Akita H; Dang CV
Mol Cell Biol; 1992 Jul; 12(7):3130-7. PubMed ID: 1620120
[TBL] [Abstract][Full Text] [Related]
12. Determination of binding constant of transcription factor myc-max/max-max and E-box DNA: the effect of inhibitors on the binding.
Park S; Chung S; Kim KM; Jung KC; Park C; Hahm ER; Yang CH
Biochim Biophys Acta; 2004 Feb; 1670(3):217-28. PubMed ID: 14980448
[TBL] [Abstract][Full Text] [Related]
13. Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc.
Blackwood EM; Eisenman RN
Science; 1991 Mar; 251(4998):1211-7. PubMed ID: 2006410
[TBL] [Abstract][Full Text] [Related]
14. A dominant-negative mutant of Max that inhibits sequence-specific DNA binding by Myc proteins.
Billaud M; Isselbacher KJ; Bernards R
Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2739-43. PubMed ID: 8464883
[TBL] [Abstract][Full Text] [Related]
15. Variant Max protein, derived by alternative splicing, associates with c-Myc in vivo and inhibits transactivation.
Arsura M; Deshpande A; Hann SR; Sonenshein GE
Mol Cell Biol; 1995 Dec; 15(12):6702-9. PubMed ID: 8524235
[TBL] [Abstract][Full Text] [Related]
16. Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT).
Kyo S; Takakura M; Taira T; Kanaya T; Itoh H; Yutsudo M; Ariga H; Inoue M
Nucleic Acids Res; 2000 Feb; 28(3):669-77. PubMed ID: 10637317
[TBL] [Abstract][Full Text] [Related]
17. Mga, a dual-specificity transcription factor that interacts with Max and contains a T-domain DNA-binding motif.
Hurlin PJ; Steingrìmsson E; Copeland NG; Jenkins NA; Eisenman RN
EMBO J; 1999 Dec; 18(24):7019-28. PubMed ID: 10601024
[TBL] [Abstract][Full Text] [Related]
18. Constitutive expression of ectopic c-Myc delays glucocorticoid-evoked apoptosis of human leukemic CEM-C7 cells.
Medh RD; Wang A; Zhou F; Thompson EB
Oncogene; 2001 Aug; 20(34):4629-39. PubMed ID: 11498786
[TBL] [Abstract][Full Text] [Related]
19. Low molecular weight inhibitors of Myc-Max interaction and function.
Yin X; Giap C; Lazo JS; Prochownik EV
Oncogene; 2003 Sep; 22(40):6151-9. PubMed ID: 13679853
[TBL] [Abstract][Full Text] [Related]
20. HMG-I/Y, a new c-Myc target gene and potential oncogene.
Wood LJ; Mukherjee M; Dolde CE; Xu Y; Maher JF; Bunton TE; Williams JB; Resar LM
Mol Cell Biol; 2000 Aug; 20(15):5490-502. PubMed ID: 10891489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
